Literature DB >> 10398738

Influence of patient characteristics and treatment options on outcome of patients with prosthetic aortic graft infection.

J M Seeger1, M R Back, J L Albright, L M Carlton, T R Harward, P S Kubulis, T C Flynn, T S Huber.   

Abstract

This study was undertaken to determine the influence of patient characteristics and treatment options on survival and limb loss after treatment of prosthetic aortic graft infection. Fifty-three patients treated for prosthetic aortic graft infection were reviewed. Twenty-three presented with groin infection, 12 with sepsis, 10 with aortoenteric fistula, 4 with limb ischemia, and 4 with pseudoaneurysm. Treatment included staged extraanatomic bypass (EAB) plus graft excision in 23 patients, simultaneous EAB and graft excision in 18, in situ graft replacement in 5, and local therapy only in 7. Axillofemoral bypass was done for revascularization in 53 limbs and axillopopliteal bypass in 16 limbs. The results of this study showed that morbidity and mortality of prosthetic aortic graft infection is influenced by the presentation and type of treatment of the infected graft. Staged axillofemoral bypass (when possible) plus graft excision appears to be associated with acceptable outcome (survival with limb salvage in 74%).

Entities:  

Mesh:

Year:  1999        PMID: 10398738     DOI: 10.1007/s100169900276

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  Financial impact of tertiary care in an academic medical center.

Authors:  T S Huber; L M Carlton; D G O'Hern; N S Hardt; C Keith Ozaki; T C Flynn; J M Seeger
Journal:  Ann Surg       Date:  2000-06       Impact factor: 12.969

2.  Secondary aortoenteric fistula.

Authors:  M A Mohammadzade; M Hossain Akbar
Journal:  MedGenMed       Date:  2007-08-01

3.  Current options in prosthetic vascular graft infection: comparative analysis of 63 consecutive cases.

Authors:  Marcin Gabriel; Fryderyk Pukacki; Pawel Checinski; Grzegorz Oszkinis; Michal Stanisic; Maciej Zielinski; Katarzyna Pawlaczyk
Journal:  Langenbecks Arch Surg       Date:  2004-03-16       Impact factor: 3.445

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.